Cipla Limited

Price Chart

Risk-Adjusted Performance

Cipla Limited (CIPLA) Price Performance

Cipla Limited (CIPLA) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1230.80, up 0.52% from the previous close.

Over the past year, CIPLA has traded between a low of INR1192.40 and a high of INR1663.60. The stock has lost 16.3% over this period. It is currently 26.1% below its 52-week high.

Cipla Limited has a market capitalization of $997.21B, with a price-to-earnings ratio of 21.93.

About Cipla Limited

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.